Dr Anita R Juvvadi, MD - Medicare Pediatrics in Mountain View, CA

Dr Anita R Juvvadi, MD is a medicare enrolled "Pediatrics - Adolescent Medicine" physician in Mountain View, California. Her current practice location is 2500 Hospital Dr, Bldg #12, Mountain View, California. You can reach out to her office (for appointments etc.) via phone at (650) 968-4535.

Dr Anita R Juvvadi is licensed to practice in California (license number A55484) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1457325797.

Contact Information

Dr Anita R Juvvadi, MD
2500 Hospital Dr, Bldg #12,
Mountain View, CA 94040-4106
(650) 968-4535
(650) 968-4542



Physician's Profile

Full NameDr Anita R Juvvadi
GenderFemale
SpecialityPediatrics - Adolescent Medicine
Location2500 Hospital Dr, Mountain View, California
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1457325797
  • Provider Enumeration Date: 02/14/2006
  • Last Update Date: 02/02/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 7214300482
  • Enrollment ID: I20230309000331

Medical Identifiers

Medical identifiers for Dr Anita R Juvvadi such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1457325797NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2080A0000XPediatrics - Adolescent Medicine A55484 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Anita R Juvvadi allows following entities to bill medicare on her behalf.
Entity NameLa Clinica De La Raza Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144336181
PECOS PAC ID: 1557258282
Enrollment ID: O20040227001016

News Archive

Clot-dissolving drugs such as tPA may help detect potentially deadly leg clots

A possible diagnostic use for clot-dissolving drugs such as tPA has been found by Medical College of Georgia researchers working to improve a test that identifies potentially deadly blood clots in the legs.

Golden Meditech continues share repurchase program

Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, today announced that the Group has been repurchasing its shares from the market in the month of December 2011, accumulating a total of 58,104,000 shares in December 2011, equivalent to 2.84% of the Group's total outstanding shares as of today at a weighted average price of HK$0.84 per share.

Enrollment for sham-controlled study of radiation therapy for treatment of wet AMD announced

Oraya Therapeutics, Inc., announced today that enrollment is now underway for the first ever masked and sham-controlled study to demonstrate the efficacy and safety of radiation therapy for the treatment of wet age-related macular degeneration (AMD).

Biological factors, cell behaviour drive tumour growth contributing to therapy failure and relapse

Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.

Researchers find brain abnormalities in Zika virus infected fetuses

In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Baylor College of Medicine Department of Obstetrics and Gynecology, Houston, Texas partnered with the Maternal-Fetal Unit, CEDIFETAL, Centro de Diagnostico de Ultrasonido e Imagenes, CEDIUL, Barranquilla, Columbia and the Unidad De Fertildad Y Genetica De Cartagena, Cartagena de Indias, Columbia, to create the study, Characterization of brain malformations and volume assessment in fetuses with Zika Virus infection using MRI.

Read more Medical News

› Verified 2 days ago

Entity NameMarin City Health And Wellness Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285804948
PECOS PAC ID: 1052451259
Enrollment ID: O20091221000011

News Archive

Clot-dissolving drugs such as tPA may help detect potentially deadly leg clots

A possible diagnostic use for clot-dissolving drugs such as tPA has been found by Medical College of Georgia researchers working to improve a test that identifies potentially deadly blood clots in the legs.

Golden Meditech continues share repurchase program

Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, today announced that the Group has been repurchasing its shares from the market in the month of December 2011, accumulating a total of 58,104,000 shares in December 2011, equivalent to 2.84% of the Group's total outstanding shares as of today at a weighted average price of HK$0.84 per share.

Enrollment for sham-controlled study of radiation therapy for treatment of wet AMD announced

Oraya Therapeutics, Inc., announced today that enrollment is now underway for the first ever masked and sham-controlled study to demonstrate the efficacy and safety of radiation therapy for the treatment of wet age-related macular degeneration (AMD).

Biological factors, cell behaviour drive tumour growth contributing to therapy failure and relapse

Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.

Researchers find brain abnormalities in Zika virus infected fetuses

In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Baylor College of Medicine Department of Obstetrics and Gynecology, Houston, Texas partnered with the Maternal-Fetal Unit, CEDIFETAL, Centro de Diagnostico de Ultrasonido e Imagenes, CEDIUL, Barranquilla, Columbia and the Unidad De Fertildad Y Genetica De Cartagena, Cartagena de Indias, Columbia, to create the study, Characterization of brain malformations and volume assessment in fetuses with Zika Virus infection using MRI.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Anita R Juvvadi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Anita R Juvvadi, MD
2500 Hospital Dr, Bldg #12,
Mountain View, CA 94040-4106

Ph: (650) 968-4535
Dr Anita R Juvvadi, MD
2500 Hospital Dr, Bldg #12,
Mountain View, CA 94040-4106

Ph: (650) 968-4535

News Archive

Clot-dissolving drugs such as tPA may help detect potentially deadly leg clots

A possible diagnostic use for clot-dissolving drugs such as tPA has been found by Medical College of Georgia researchers working to improve a test that identifies potentially deadly blood clots in the legs.

Golden Meditech continues share repurchase program

Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, today announced that the Group has been repurchasing its shares from the market in the month of December 2011, accumulating a total of 58,104,000 shares in December 2011, equivalent to 2.84% of the Group's total outstanding shares as of today at a weighted average price of HK$0.84 per share.

Enrollment for sham-controlled study of radiation therapy for treatment of wet AMD announced

Oraya Therapeutics, Inc., announced today that enrollment is now underway for the first ever masked and sham-controlled study to demonstrate the efficacy and safety of radiation therapy for the treatment of wet age-related macular degeneration (AMD).

Biological factors, cell behaviour drive tumour growth contributing to therapy failure and relapse

Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal cancer, they found that genetic mutations, regarded by many as the chief suspect driving cancer growth, are only one piece of the puzzle. The team discovered that biological factors and cell behaviour - not only genes - drive tumour growth, contributing to therapy failure and relapse.

Researchers find brain abnormalities in Zika virus infected fetuses

In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Baylor College of Medicine Department of Obstetrics and Gynecology, Houston, Texas partnered with the Maternal-Fetal Unit, CEDIFETAL, Centro de Diagnostico de Ultrasonido e Imagenes, CEDIUL, Barranquilla, Columbia and the Unidad De Fertildad Y Genetica De Cartagena, Cartagena de Indias, Columbia, to create the study, Characterization of brain malformations and volume assessment in fetuses with Zika Virus infection using MRI.

Read more News

› Verified 2 days ago


Pediatrics Doctors in Mountain View, CA

Melanie Alexandra Atmadja,
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 701 E. El Camino Real, Mountain View, CA 94040
Phone: 650-934-7956    
Kaitlin Duke Lemei, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 701 E. El Camino Real, Mountain View, CA 94040
Phone: 650-934-7000    
Swarnapali R.p. Seneviratna, MD
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 900 Miramonte Ave, Mountain View, CA 94040
Phone: 650-965-3323    
Michaella Okihara, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 701 E El Camino Real, Mountain View, CA 94040
Phone: 650-934-7956    
George A. Johnson, MD
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 555 Castro St, Mountain View, CA 94041
Phone: 650-903-3000    
Patricia Samson, MD
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 701 E El Camino Real, Mountain View, CA 94040
Phone: 650-934-7956    
Dr. Christina Vu, M.D,
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 701 E El Camino Real, Mountain View, CA 94040
Phone: 650-404-8370    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.